This Week in Psychedelics - 9.17.21

Cannabis

• FDA And CDC Issue Warnings On Delta-8 THC Products Derived From Hemp (Marijuana Moment)

• World Anti-Doping Agency Reviews Marijuana Ban For Athletes Following Pushback On Richardson Suspension (Marijuana Moment)

• California: Lawmakers Advance Legislation Providing for Medical Cannabis Use in Hospitals (NORML)

• Runner’s High Gets New Meaning (The Wall Street Journal)

• Cannabis-Related Arrests in Virginia Decrease By 90 Percent After Legalization (High Times)

• Cannabis use linked to subtle abnormalities in speech production (PsyPost)

• Wolf administration ordered to reveal details of cannabis use as drug addiction treatment (The Philadelphia Inquirer)

• Virginia Judge Jails Woman For Using Marijuana Before Testifying Against Alleged Domestic Violence Abuser (Marijuana Moment)

• New Jersey Has Expunged A Third Of A Million Marijuana Convictions Since July (Marijuana Moment)

• New Hampshire Lawmakers Take First Step To Put Marijuana Legalization On 2022 Ballot (Marijuana Moment)

• Michigan Medical Marijuana Activists Push Back Against Alleged Corporate Effort To Restrict Home Cultivation (Marijuana Moment)

LSD

• LSD-triggered altered behaviors linked to abnormal brain communication (Medical Xpress)

• Miami student seriously injured after he jumped off roof while on LSD (Oxford Observer)

Magic Mushrooms

• First subject dosed in psilocybin trial for rare headache disorder (Pharmaphorum)

• California Activists Cleared To Collect Signatures For Psilocybin Legalization Ballot Initiative (Marijuana Moment)

• Psychedelic shroom fest gets green light from University of Michigan (MLive)

• What Happens When Dogs Eat Shrooms (DoubleBlind)

• Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation Fragile X Syndrome Treatment (Psilocybin Alpha)

MDMA

• Turns Out Your DNA Sticks to MDMA Caps. That Could Help Police Track Down Drug Dealers. (VICE)

• Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline (Psilocybin Alpha)

• Letter With MDMA Sent From the UK House of Commons to Prisoner (EDMTunes)

DMT

• How to Integrate Those Difficult-to-Remember DMT Experiences (Sam Woolfe)

• DMT vs. Mushrooms: Are We All Tripping On The Same Thing? (DoubleBlind)

5-MeO-DMT

• Tourists Are Now Smoking Toad Venom in Mexico’s Hipster Town Tulum (VICE)

Peyote

• Santa Cruz City Council Removes Peyote from List of Decriminalized Psychedelics (Good Times Santa Cruz)

Iboga

• Post-9/11 war vets go to Mexico to treat trauma with a psychedelic that's illegal in the US (Stars and Stripes)

Novel Psychoactive Substances

• COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs (Psilocybin Alpha)

• Mindset Pharma Further Validates Lead Candidate, MSP-1014, as a Next Generation Psilocybin Analog through Drug Discrimination Assay (Psilocybin Alpha)

Nitrous Oxide

• Nitrous-oxide: Laughing gas hits a new high in Ireland (The Irish Times)

Ketamine

• Colorado attorney general report found Aurora police racially biased and fire department administered ketamine illegally (CNN)

• Ketamine monotherapy reduces suicidal ideation in adults with depression (Healio)

• Psychable is the First Ketamine-Assisted Therapy Company to Offer a Buy One, Give One Program (GlobeNewswire)

• Sharon Osbourne Says She Underwent Ketamine Therapy After Leaving The Talk amid Controversy (People)

• Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression (Psilocybin Alpha)

Miscellaneous

• Detroit Voters Will Decide On Psychedelics Decriminalization Ballot Measure In November (Marijuana Moment)

• Michigan Lawmaker Introduces Psychedelics Decriminalization Bill (Forbes)

• Addiction specialists accused of 'massive conflict of interest' for ties to drug-testing industry (CBC)

• Tim Ferriss Gift Creates Journalism Fellowships at Berkeley’s new Center for Science of Psychedelics (UC Berkeley Graduate School of Journalism)

• Seattle bid to decriminalize psychedelics could have ‘profound’ effect on treating addiction (MyNorthwest.com)

• Psychedelic medicine comes to the VA (The Psychedelic Renaissance)

• House Could Vote On Psychedelics Research For Military And Marijuana Banking As Part Of Defense Bill (Marijuana Moment)

• Survey: U.S. College Students Drank Less, Used More Marijuana And Psychedelics During Covid-19 (Forbes)

• Congressional Panel Votes To Repeal Drug Conviction Penalty Blocking Education Tax Credit (Marijuana Moment)

• Psychedelic Use on the Rise As Gen Z Seeks To ‘Enhance Connectedness’ (VICE)

• Seattle Councilmember Says He’ll Introduce Psychedelics Decriminalization Measure By Year’s End (Marijuana Moment)

• A Renaissance for Psychedelics Could Fill a Long-Standing Treatment Gap for Psychiatric Disorders (Scientific American)

• Ecstasy, LSD and magic mushrooms: are these drugs the future of therapy? (The Guardian)

• Fear of Death Impacts Quality of Life-How Psychedelics Can Help (Psychedelic Science Review)

• Washington State Activists Announce 2022 Drug Decriminalization Ballot Campaign (Marijuana Moment)

• Digital Psychedelia: Hidden Experience and the Challenge of Paranoia (Somatosphere)

• A Workbook for Psychedelic Integration Focuses on Life’s Big Questions (Lucid News)

• The impact and importance of psychedelic medicine (Open Access Government)

• 'Nine Perfect Strangers' is a deranged portrait of psychedelic wellness retreats (Mic)

• Understanding ‘Spiritual Emergency’ in the Context of Psychedelics (Psychedelics Today)

• What Substances Are More Likely To Be Contaminated With Fentanyl? (Lucid News)

• Discovering New Psychedelic Drugs (Reality Sandwich)

• Studying Psychedelics Pt I: North American Research (Truffle Report)

• The Therapeutic Effects of Psychedelics: 2A or Not 2A? – Part 1 (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 9.10.21

Cannabis

• The Mysterious Ingredients in Your Cannabis Vaporizer — and the Health Risks They May Pose (Discover Magazine)

• Ecuador Takes Giant Steps Towards Cannabis Legalisation (TalkingDrugs)

• The cannabis industry is booming, but for many Black Americans the price of entry is steep (The Guardian)

• California Will Use Marijuana Tax Dollars To Support Cultivator Environmental Clean-Up, State Announces (Marijuana Moment)

• South Dakota: Lawmakers Seek to Repeal Vote Permitting Home Cultivation of Medical Cannabis (NORML)

• Marijuana Legalization Doesn’t Lead To Increased Youth Use, American Medical Association Study Finds (Marijuana Moment)

• Marijuana Possession Arrests Plunge in NYC Post-Legalization (Filter)

• Daily marijuana use among US college students reaches new 40-year high (University of Michigan)

• Drones to Deploy in California County to Detect Illicit Pot Operations (High Times)

• Texas: Expansions to Medical Cannabis Access Law Take Effect (NORML)

• Medical cannabis unlikely to benefit most chronic pain patients, international researchers say (STAT)

• Young adult cannabis consumers nearly twice as likely to suffer from a heart attack, research shows (CNN)

• Maryland Lawmakers Take First Step Toward Putting Marijuana Legalization On 2022 Ballot (Marijuana Moment)

• Nebraska Activists Submit Two Medical Marijuana Initiatives For 2022 Ballot (Marijuana Moment)

• Wyoming Activists Jumpstart Signature Gathering For 2022 Marijuana Ballot Initiatives (Marijuana Moment)

• Missouri voters might see two adult-use cannabis measures in 2022 (Marijuana Business Daily)

LSD

• Shia LaBeouf Filmed Himself On LSD For This Role (TheThings)

• Kacey Musgraves says she was on LSD listening to Bach when she came up with the idea for her new album 'Star-crossed' (INSIDER)

Magic Mushrooms

• Oregon Psilocybin Panel Teams Up With Harvard To Research Psychedelic History And Impacts Of Reform (Marijuana Moment)

• Amanita Muscaria, the Real Life Mushroom We Know From Disney Movies (Literary Hub)

• Coldplay’s Chris Martin recounted his hallucinogenic experience with mushrooms (Vegan News)

• Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes (Psilocybin Alpha)

MDMA

• Lorde reveals she was on MDMA while making 'Melodrama' and says each of her albums can be distinguished by drugs she was using at the time (Yahoo! News)

• MDMA-assisted couples therapy may help maximize recovery among patients with PTSD (PsyPost)

DMT

• Joe Rogan Test Positive for Covid, Says He Is Smoking Ivermectin-DMT Hybrid for Treatment (ValueWalk)

• DMT vs. Mushrooms: Are We All Tripping On The Same Thing? (DoubleBlind)

• Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose (Psilocybin Alpha)

Ayahuasca

• Your Grandma’s Guide to Ayahuasca (Lucid News)

San Pedro

• Consuming San Pedro: Everything You Need To Know (The Third Wave)

Novel Psychoactive Substances

• Here's Why There's So Much Fake MDMA in the UK Right Now (VICE)

• Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial (Psilocybin Alpha)

• Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its Novel Psilocybin-Inspired Clinical Candidate (Psilocybin Alpha)

• Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104 (Psilocybin Alpha)

Nitrous Oxide

• Laughing Gas Could Become Illegal Because the UK Can’t Stand the Sight of Rubbish (VICE)

Ketamine

• Researchers develop statistical model to characterize how ketamine anesthesia affects the brain (News-Medical.net)

• Intranasal ketamine could effectively treat phantom pain (Pharmaceutical Technology)

• Comparing the impacts of propofol and ketamine on the brain (Medical Xpress)

• atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression (Psilocybin Alpha)

Miscellaneous

• Possessing And Cultivating Psychedelics Would Be Legalized In Michigan Under New Senate Bill (Marijuana Moment)

• The worldview-changing drugs poised to go mainstream (BBC)

• Why investors are turning toward psychedelic health care companies (Fortune)

• No, VR Will Not Give You A Psychedelic Trip (Psychedelics Today)

• Field Trip Health opens Europe's first psychedelic therapy healthcare facility (PR Newswire)

• Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds (Psilocybin Alpha)

• SoundMind opens a psychedelic clinic in West Philly as momentum builds for treatment of depression, PTSD with mind-altering drugs (The Philadelphia Inquirer)

• CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development (Psilocybin Alpha)

• Mount Sinai’s Center for Psychedelic Psychotherapy and Trauma Research Receives $5 Million Grant From The Bob & Renee Parsons Foundation (Mount Sinai)

• Wesana Health Announces Closing of PsyTech Acquisition (Psilocybin Alpha)

• Researchers Debate the Role of Mysticism in Psychedelic Science (Lucid News)

• Glutamate’s Role in Rapidly-Acting Antidepressants (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 9.3.21

Cannabis

• Appeals court rejects lawsuit seeking to force DEA to reschedule marijuana (Marijuana Business Daily)

• Anti-Pot Author Alex Berenson Gets Permanent Twitter Ban (High Times)

• How Much Legal Cannabis Is In California? It’s A State Secret. (Forbes)

• Allowing Public Marijuana Smoking Leads To Bigger NYC Arrest Decline Than In Other Legalized Places (Marijuana Moment)

• Fakkuappu: Japan Struggles with Cannabis Reform (High Times)

• Senators Flooded With Input On Federal Marijuana Legalization Bill (Marijuana Moment)

• Big Pharma Seizes Brazilian Market While Medical Cannabis Bill is Stalled (TalkingDrugs)

• Alabama medical cannabis program might roll out slower than expected (Marijuana Business Daily)

• Swiss Doctors to Prescribe Cannabis Without “Exceptional Authorization” (High Times)

• Legalization Nation: The Dispensary Divide (The Nib)

• New Group Files Another Missouri Marijuana Legalization Initiative For 2022 Ballot (Marijuana Moment)

• Ohio Marijuana Activists Cleared To Collect Signatures For 2022 Legalization Ballot Initiative (Marijuana Moment)

LSD

• How Dock Ellis Made Baseball History on LSD (DoubleBlind)

Magic Mushrooms

• Denver Psychedelics Activists Push To Expand Psilocybin Decriminalization To Allow Gifting And Communal Use (Marijuana Moment)

• Yale researchers discover healing effects of psychedelic drug (Yale Daily News)

• Heroic Hearts Project announces new study with Imperial College London into the physiological and psychological effects of psilocybin on veterans. (Volteface)

• 'Psychedelic renaissance' sees first legal collection of Australia's medicinal magic mushrooms (Australian Broadcasting Corporation)

• The Tragic Story Of Magic Truffles: The Elusive Wild Psilocybe (DoubleBlind)

• Red Light Holland Successfully Completes Canada’s Largest Legal Sale and Import of Psilocybe Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit (Psilocybin Alpha)

DMT

• Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics (Benzinga)

Ayahuasca

• A single dose of ayahuasca improves self-perception of speech performance in socially anxious people, study finds (PsyPost)

• Wilma Mahua Campos, Shipibo Ayahuasquera (Chacruna)

• The Importance of Traditional Ayahuasca Techniques with Carlos Tanner (EntheoNation)

5-MeO-DMT

• Psychedelic Toads Emerge In Arizona During Monsoon Season (iHeartRadio)

San Pedro

• The Effects of Mescaline in the San Pedro Cactus (The Third Wave)

Novel Psychoactive Substances

• Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic Analogs Demonstrate a Significantly Improved Safety Profile in Preclinical Results (Psilocybin Alpha)

Nitrous Oxide

• Nitrous oxide: Patel orders Laughing gas review to decide on potential new law (BBC)

Ketamine

• Cops and Paramedics Involved in Elijah McClain’s Death Charged With Homicide (VICE)

Miscellaneous

• Drug Users Are Suing the Canadian Government Over the War on Drugs (VICE)

• DEA Proposes Massive Increase In Marijuana And Psilocybin Production For Research To Develop FDA-Approved Medicines (Marijuana Moment)

• 'QAnon Shaman' to plead guilty in US Capitol riot case (CNN)

• What Is the ‘Collective Unconscious’ and How Can It Help Us Understand Psychedelic Experiences? (Psychedelics Today)

• Can Psychedelics Promote Social Justice and Change the World? (Chacruna)

• Seattle Should Decriminalize All Drugs, City Task Force On Overdose Crisis Recommends (Marijuana Moment)

• Jon Hopkins Announces New Album Music for Psychedelic Therapy, Shares New Song: Listen (Pitchfork)

• Meet the women who regularly microdose psychedelics (Cosmopolitan)

• Glow Time: PsychLight Brings a Powerful Tool to Psychedelic Research (Psychedelic Science Review)

• New Psychedelic Therapy Clinic Opens in Charleston (Johnson City Press)

• Psychedelics Co. Synthesis Institute Closes $7.25M Series A Funding Through Non-Traditional VC Path (Benzinga)

• Psychedelics—The New Psychiatric Craze (Mad in America)

• Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers; Also Launches Training Programs To Educate A New Generation Of Psychedelic Clinicians (Psilocybin Alpha)

• Psychedelics in Recovery: 12-Step Peer Support Program (Truffle Report)

• Legal Psychedelic Retreats – What They Are & Where to Find Them (EntheoNation)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Month in Psychedelics - August 2021

Welcome back to Think Wilder. A lot happened in the world of psychedelics this month, including the launch of a new psychedelic peer support app, innovations in wearable psychedelics, trials looking into using psychedelics to treat gambling addiction and eye disease, new psychedelic research centers, innovative drug checking technologies, and much more.

Here’s a video version of this month’s recap if you’d prefer to watch the update instead:

There’s a lot to get through this month, so without further ado, let’s jump into the news:

Policy

Wins

Louisiana’s cannabis decriminalization law went into effect on August 1st, putting an end to the possibility of jail time for possessing 14 grams or less of the plant. Anyone who exceeds the limit will face a fine of $100, regardless of whether they have any prior cannabis convictions.

The Eastern Band of Cherokee Indians in North Carolina legalized its own medical marijuana market, although many details remain to be determined. This is the latest in a growing trend of Native Americans entering the cannabis industry, particularly in states that already have their own medical or recreational cannabis markets.

Future

A California bill to legalize the possession of psychedelics has been delayed until next year to hopefully strengthen its case and increase the chances that it will be approved. Several other states will have cannabis and psychedelic drug policy reforms on the ballot in 2022 as well.

Industry

Wearable psychedelics are being developed that are capable of dispensing small doses of drugs like ketamine and DMT to treat a variety of mental health and physical conditions. Some will give patients the ability to fine-tune their dose to control their experience, while other methods will automatically administer doses to the wearer, such as a transdermal psilocybin patch intended to cut down on potential negative side effects.

Beckley Psytech raised $80 million during its Series B financing round, proving once again that venture capital investors with deep pockets see potential in the nascent psychedelic industry.

When you think of treating mental health conditions, salvia divinorum might not come first to mind. But atai Life Sciences thinks the divine sage might have some potential, and the company launched a subsidiary called Revixia Life Sciences that will investigate the potential uses for salvinorin a, the primary active ingredient in the plant.

Research

Several enlightening psychedelic research studies were published this month. Among the biggest was a review that found people with psychedelic experiences under their belt have healthier habits on average. And another study found that mixing psychedelics and SSRIs is safe for the most part, although there are a few exceptions.

Psychedelic research studies often focus on common mental health conditions such as depression and PTSD, but new applications are being investigated all the time. Earlier this month month Awakn Life Sciences initiated a ketamine treatment study for gambling addiction and PharmaDrug formed a collaboration with the Terasaki Institute to study the use of DMT and other tryptamines to treat eye disease.

Just a few years ago there weren’t any research centers dedicated to psychedelic science, but new ones are making their way into the world all the time and two more were announced just this month. The Usona Institute broke ground on its Wisconsin-based Transdisciplinary Center for Research in Psychoactive Substances, which is slated to open in 2024. Down under in Melbourne, Australia, a first-of-its-kind psychedelic therapy research center is expected to begin work on developing psychedelic medicines later this year, and clinical studies will start in 2022.

Harm Reduction

The Fireside Project has been helping people process psychedelic experiences via its free peer support phone line since it launched in April, but this month the organization took things to the next level by releasing a psychedelic peer support app. Now psychonauts in need of support can find help on either the phone or via chat, which may be helpful for people who prefer one form of communication over another.

Drug checking is an essential practice for any responsible psychonaut, and new technologies are coming out that will ensure more innovative and accurate results than ever before. The popular harm reduction organization known as DanceSafe released a new ketamine test kit (called the Morris reagent) that was engineered to identify the difference between ketamine and common analogues like DCK and 2FDCK. And a startup called Miraculix took things one step further by creating rapid at-home test kits that can assess the potency of various psychoactive drugs, including MDMA, LSD, and psilocybin.

Denver led the way once again by launching America’s first psychedelic harm reduction training program for first responders. This is a big step because not only does this mean that the Mile High City’s police, firefighters, paramedics, hospital dispatchers, and mental health workers will be equipped with the knowledge needed to handle a psychedelic trip gone wrong, but it also sets the stage for future similar programs to spread to the rest of the country.

Miscellaneous

Almost a year after Ann Arbor’s city council voted to decriminalize psychedelics, lawmakers designated September as Entheogenic Plants and Fungi Awareness Month. What an encouraging sign to see psychedelics being understood and celebrated at a city-wide level!

Some companies are beginning to push the concept of at-home genetic testing to tell you whether you’re likely to have a bad trip, but an investigative report found that the results are unreliable. And on top of that, this type of testing can also put misleading and distressing ideas in your head too.

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

This Week in Psychedelics - 8.27.21

Cannabis

• Legal Pot Delivery Sales Launch in Denver, Colorado (High Times)

• New Jersey: Many Cities Opting Out of Retail Marijuana Sales Ahead of Rollout (NORML)

• New Mexico Approves Cannabis Rules and Prepares for Legalization (High Times)

• Manitoba and Quebec still won’t let you grow weed at home (Leafly)

• Third North Carolina Senate Committee Approves Medical Marijuana Legalization Bill (Marijuana Moment)

• Marijuana firms and advocates struggle as Instagram targets accounts (Marijuana Business Daily)

• The Ecology of Good Weed (Nautilus)

• What is delta-10? (Leafly)

• Feds And California Governor Exploring Rules For Medical Marijuana Use In Hospitals (Marijuana Moment)

• Commercial Drivers Consume Cannabis More than Any Other Drug, Data Shows (High Times)

• Ohio Attorney General Certifies 2022 Marijuana Legalization Ballot Petition (Marijuana Moment)

• Aurora sends first shipment of ‘free’ marijuana to France (Marijuana Business Daily)

LSD

• Microdosing LSD Makes Me a Better Mom (Psychedelics Today)

Magic Mushrooms

• Will A Psilocybin Patch Be The Next Big Thing In Psychedelics? (Forbes)

• Psilocybin Therapy and the Rise of Existential Medicine (DoubleBlind)

• All-Inclusive Magic Mushroom Retreats Are the New Luxury ‘Trips’ (Bloomberg)

• Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida (Psilocybin Alpha)

• The Rise of Shroom Slang and the New Language of Tripping (DoubleBlind)

MDMA

• Women Behind the Scenes in Psychedelic Science: Making MDMA a Legal Medicine with Amy Emerson (Chacruna)

DMT

• Psilera Collaborates with the National Institute on Drug Abuse (NIDA) to Research DMT and New Analogues to Combat Addiction (Psilocybin Alpha)

• How Long Does DMT Last? (Healing Maps)

• PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study (Psilocybin Alpha)

• DMT-Inspired Artwork by Harry Pack (Sam Woolfe)

• What Is DMT? From Its Purpose To Understanding Its Side Effects (Healing Maps)

Ayahuasca

• What Do Ayahuasca Visions Really Mean? (Reality Sandwich)

• Ancestral Psychedelic Therapy Using Ayahuasca (Benzinga)

• An Ayahuasca Research Break Down (Reality Sandwich)

5-MeO-DMT

• Spanish couple arrested over toad-venom and ayahuasca rituals (The Guardian)

Peyote

• What Is Peyote And How Does It Work? (Healing Maps)

Salvia Divinorum

• Twitter Thread Of The Craziest Experiences People Had Tripping On Salvia Proves We Were Lucky To Survive The 2000s (BroBible)

Novel Psychoactive Substances

• Scientists Isolate Two New Compounds from Toad Venom (Psychedelic Science Review)

• Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired Psychedelic Drug Candidates (Psilocybin Alpha)

Nitrous Oxide

• Neuropathy After Recreational Use of Laughing Gas (MedPage Today)

Ketamine

• There’s Finally an Accurate Drug-Checking Kit for Ketamine (Filter)

• Same But Different: Antidepressant Mechanisms of Psilocybin and Ketamine (Psychedelic Science Review)

• Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling Addiction Led by Professor Celia Morgan (Yahoo! Finance)

• Ketamine For Pain: Understanding The Pros And Cons (Healing Maps)

• HMNC Brain Health and Develco Pharma Partner to Initiate Ketamine Study Targeting Treatment-Resistant Depression (TRD) (Yahoo! Finance)

Miscellaneous

• California Bill To Legalize Psychedelics Possession Put On Pause Until 2022 (Marijuana Moment)

• Wisconsin University Launches Psychedelics Center With Goal Of Increasing Diversity In Research (Marijuana Moment)

• Startup Miraculix Creates First Rapid, Mobile Test Kits For Concentrations of MDMA, LSD, and Psilocybin (Lucid News)

• Psychedelics and Breastfeeding: What We Know—and Don’t Know—About a Taboo Subject (DoubleBlind)

• Study to Determine if Psychedelics Help to Quit Cigarette Smoking (High Times)

• Freaks of Color Tell Psychedelic Stories That Inspire (Lucid News)

• The Stamets Stack: Can Microdosing Really Change Your Brain? (DoubleBlind)

• Biden’s Extension of Title 42 Subjects Refugees to More Drug-War Violence (Filter)

• This West Philly Doctor Says Psychedelic-Assisted Therapy Could Change Your Life (Philadelphia Magazine)

• 10 Best Trippy Festivals and Events Coming Up (Reality Sandwich)

• UK Venture Round Shines Spotlight on Europe’s Psychedelics Scene (Labiotech.eu)

• Psychedelic-Induced Theism: Common Misconceptions (Truffle Report)

• The Meaning of Psychedelics (Maps of the Mind)

• Why the Term ‘Drug’ is Difficult to Clearly Define (Sam Woolfe)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.